PREVALENCE OF VARIOUS ETIOPATHOGENIC VARIANTS OF CHRONIC DIFFUSE LIVER DISEASES

Chronic diffuse liver diseases (CDLD) is a collective concept that unites diseases of various etiologies, accompanied by the development of diffuse damage to the liver parenchyma, which is characterized by deviations from the norm in biochemical markers of liver function and lasts more than 6 months. In recent decades, CDPD has been the subject of active study by hepatologists and close attention from practicing physicians. First of all, this is due to the fact that the prevalence of liver diseases is increasing every year all over the world, and most often this pathology develops in people of working age, significantly reducing their quality of life. Data from modern literature indicate that currently chronic liver diseases occupy a significant place among the causes of early disability and mortality of the population. On average, there are more than 2 billion people worldwide suffering from chronic diffuse liver disease (CDLD), which is 100 times higher than the prevalence of HIV infection. In this case, the main contingent of patients becomes, as a rule, the able-bodied, socially active part of the population. CDPD include a wide range of nosologically independent inflammatory diseases of various etiologies Thus, liver lesions of various etiologies occur in approximately the same sequence, called the “liver continuum”, the final link of which is HCC. Therefore, not only effective therapy and measures to prevent the development of CDPD themselves, but also the ability to productively intervene in this continuum are currently one of the most pressing problems of modern hepatology. Given the paucity of epidemiological data from regions of Asia, Africa and Latin America, and the lack of consistency in regional and age-specific patterns of prevalence of chronic diffuse liver disease, further research is required to identify the global burden of the disease. The purpose of this review was to search for literature data on the prevalence of diffuse infiltrative and inflammatory liver diseases of various etiopathogenesis. To achieve this goal, publications of foreign authors in the Scopus and Pubmed databases were analyzed. Taking into account the depth of the search - the last 10 years, the language of publication - Russian, English, 38 full-text articles were included in the analysis

Authors

Institutions

Publication Details

Journal
Medicine and ecology
Published
2025-09-27
DOI
https://doi.org/10.59598/me-2305-6053-2025-116-3-35-47
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PREVALENCE OF VARIOUS ETIOPATHOGENIC VARIANTS OF CHRONIC DIFFUSE LIVER DISEASES

Elmira Iskandirova, Ainash Oshibayeva, B. Sakhova, N. Nuskabayeva et al.
Medicine and ecology
Liver Disease Diagnosis and Treatment
article

PREVALENCE OF VARIOUS ETIOPATHOGENIC VARIANTS OF CHRONIC DIFFUSE LIVER DISEASES

Elmira Iskandirova, Ainash Oshibayeva, B. Sakhova, N. Nuskabayeva, Zh. Rsalieva, N. Karabayev, L. Karimova, L. Ozbakyr
article en

Abstract

Chronic diffuse liver diseases (CDLD) is a collective concept that unites diseases of various etiologies, accompanied by the development of diffuse damage to the liver parenchyma, which is characterized by deviations from the norm in biochemical markers of liver function and lasts more than 6 months. In recent decades, CDPD has been the subject of active study by hepatologists and close attention from practicing physicians. First of all, this is due to the fact that the prevalence of liver diseases is increasing every year all over the world, and most often this pathology develops in people of working age, significantly reducing their quality of life. Data from modern literature indicate that currently chronic liver diseases occupy a significant place among the causes of early disability and mortality of the population. On average, there are more than 2 billion people worldwide suffering from chronic diffuse liver disease (CDLD), which is 100 times higher than the prevalence of HIV infection. In this case, the main contingent of patients becomes, as a rule, the able-bodied, socially active part of the population. CDPD include a wide range of nosologically independent inflammatory diseases of various etiologies Thus, liver lesions of various etiologies occur in approximately the same sequence, called the “liver continuum”, the final link of which is HCC. Therefore, not only effective therapy and measures to prevent the development of CDPD themselves, but also the ability to productively intervene in this continuum are currently one of the most pressing problems of modern hepatology. Given the paucity of epidemiological data from regions of Asia, Africa and Latin America, and the lack of consistency in regional and age-specific patterns of prevalence of chronic diffuse liver disease, further research is required to identify the global burden of the disease. The purpose of this review was to search for literature data on the prevalence of diffuse infiltrative and inflammatory liver diseases of various etiopathogenesis. To achieve this goal, publications of foreign authors in the Scopus and Pubmed databases were analyzed. Taking into account the depth of the search - the last 10 years, the language of publication - Russian, English, 38 full-text articles were included in the analysis

Medicine and ecology(3)
Ahmet Yesevi University (KZ), City Clinical Hospital No. 2 (RU)
Openalex Percentile: Top 64%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.